Image via Wikipedia
On Sept. 14, 46-year-old Hatem Faraj suffered a major heart attack while watching Monday Night Football on TV.
Tuesday, the Wesley Chapel man joined the cutting edge of heart disease research, becoming the area’s first participant in a study to see if a patient’s own stem cells can regenerate his damaged heart muscle.
The procedure he had at Pepin Heart at University Community Hospital in Tampa is part of a University of Florida research program. Its aim is improving chances of long-term survival and reducing heart transplants. Using stem cells to regenerate heart tissue has been studied for several
The prospect of treating genetic diseases with corrected stem cells grown from patients’ own bodies has moved closer, after the results of a remarkable experiment.
Scientists have successfully reprogrammed skin tissue from people with a rare form of anaemia to create powerful stem cells, while at the same time rectifying the genetic defect that causes the condition.
The corrected stem cells could be grown into blood precursor cells for therapy. As these would carry a patient’s own DNA, except for the mutation responsible for the illness, they could be transplanted without risk of rejection by the body’s immune system.
Though the research
“You can make liver. You can make pancreas. You can make bone. Therefore you can make neuro cells. You can make heart cells,” said Dr. Robert Carpenter
Yes, he said make a liver make a heart. From what? Stem cells from your teeth.
“We recently discovered that adult stem cells that don’t have the controversy related to it like embryonic cells have the ability to regenerate and treat a number of illnesses and injuries,” Carpenter said.
Stem cells are being studied to affect other disease like diabetes, kidney problems; liver problems even Parkinson’s disease. It’s in human clinical trials, and
Maria Grazia Roncarolo
It was stunning to see them closed inside of those plastic bubbles, kept far from all external contact because their immune system does not react against any foreign antigens. Today scientists can say that ADA-SCID (adenosine deaminase deficiency), a serious combined immunodeficiency caused due to a lack of the adenosine deaminase enzyme, has been definitively defeated by gene therapy developed at San Raffaele of Milan.
The final study, which combined the conclusions of clinical studies, which began in 2000 on strategic therapies developed by the HSR-TIGET (San Raffaele Telethon Institute for Gene Therapy) group, led
Apparently it looks like a simple tea bag but in reality it’s a genetically engineered concentrate able to completely revolutionize treatments for stroke patients. A special little bag called ‘CellBeads’ contains tiny capsules, each containing about 1 million stem cells. Thanks to genetic engineering techniques, stem cells taken from the bone marrow are transformed into a drug that protects brain cells from dying. This allows the cells to be rejuvenated and repair damage caused by the stroke. The stem cells are encapsulated to ‘fool’ the immune system, avoiding a rejection by the body. ‘CellBeads’ were developed by